Cargando…

Pulmonary Embolism: Contemporary Medical Management and Future Perspectives

Pulmonary embolism (PE) contributes substantially to the global disease burden. A key determinant of early adverse outcomes is the presence (and severity) of right ventricular dysfunction. Consequently, risk-adapted management strategies continue to evolve, tailoring acute treatment to the patients’...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barco, Stefano, Konstantinides, Stavros V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200624/ https://www.ncbi.nlm.nih.gov/pubmed/30402174 http://dx.doi.org/10.3400/avd.ra.18-00054

Ejemplares similares

Catheter-directed thrombolysis for acute pulmonary embolism: Where do we stand?
por: Barco, Stefano, et al.
Publicado: (2017)

Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis.
por: Roncon, Loris, et al.
Publicado: (2020)

Increased interest in acute pulmonary embolism in Italy during the COVID-19 pandemic: a google trends-based analysis
por: Roncon, Loris, et al.
Publicado: (2020)

Social determinants of health in pulmonary embolism management and outcome in hospitals: Insights from the United States nationwide inpatient sample
por: Farmakis, Ioannis T., et al.
Publicado: (2023)

Management of acute pulmonary embolism 2019: what is new in the updated European guidelines?
por: Konstantinides, Stavros, et al.
Publicado: (2020)

Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism: Insights From the Hokusai-VTE Cancer Study
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Contemporary best practice in the management of pulmonary embolism during pregnancy
por: Wiegers, Hanke M. G., et al.
Publicado: (2020)

Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis
por: Barco, Stefano, et al.
Publicado: (2019)

Fatality rates and use of systemic thrombolysis in pregnant women with pulmonary embolism
por: Hobohm, Lukas, et al.
Publicado: (2020)

Risk-Adapted Management of Acute Pulmonary Embolism: Recent Evidence, New Guidelines
por: Käberich, Anja, et al.
Publicado: (2014)

COVID-19 infection and its impact on case fatality in patients with pulmonary embolism
por: Hobohm, Lukas, et al.
Publicado: (2023)

Submassive Pulmonary Embolism: Current Perspectives and Future Directions
por: Nguyen, Phillip C., et al.
Publicado: (2021)

Interventional therapies for pulmonary embolism
por: Götzinger, Felix, et al.
Publicado: (2023)

Intermediate-Risk Pulmonary Embolism: A Review of Contemporary Diagnosis, Risk Stratification and Management
por: Machanahalli Balakrishna, Akshay, et al.
Publicado: (2022)

Thrombosis and thromboembolism related to COVID‐19: A clarion call for obtaining solid estimates from large‐scale multicenter data
por: Barco, Stefano, et al.
Publicado: (2020)

Contemporary clinical management of acute pulmonary embolism: the COPE study
por: Becattini, Cecilia, et al.
Publicado: (2022)

Cardiopulmonary exercise testing during follow-up after acute pulmonary embolism
por: Farmakis, Ioannis T., et al.
Publicado: (2023)

Cost‐of‐Illness Analysis of Long‐Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE Registry
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Contemporary Catheter-Based Treatment Options for Management of Acute Pulmonary Embolism
por: Singh, Maninder, et al.
Publicado: (2021)

Contemporary Management and Clinical Course of Acute Pulmonary Embolism: The COPE Study
por: Becattini, Cecilia, et al.
Publicado: (2023)

Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area
por: Voci, Davide, et al.
Publicado: (2022)

Contemporary Biomarkers in Pulmonary Embolism Diagnosis: Moving beyond D-Dimers
por: Gkana, Androniki, et al.
Publicado: (2022)

Review of Medical Therapies for the Management of Pulmonary Embolism
por: Panahi, Ladan, et al.
Publicado: (2021)

Temporal trends in management and outcome of pulmonary embolism: a single-centre experience
por: Ebner, Matthias, et al.
Publicado: (2019)

Future perspectives in catheter-based treatment of pulmonary embolism
por: Sharp, Andrew S P, et al.
Publicado: (2019)

Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition
por: Mavromanoli, Anna C., et al.
Publicado: (2021)

Immediate and late impact of reperfusion therapies in acute pulmonary embolism
por: Valerio, Luca, et al.
Publicado: (2019)

Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives
por: De Luca, Leonardo, et al.
Publicado: (2021)

Sex-specific and age-related seasonal variations regarding incidence and in-hospital mortality of pulmonary embolism in Germany
por: Keller, Karsten, et al.
Publicado: (2020)

Validation of a fast prognostic score for risk stratification of normotensive patients with acute pulmonary embolism
por: Hobohm, Lukas, et al.
Publicado: (2020)

Pulmonary Embolism and Pregnancy—Challenges in Diagnostic and Therapeutic Decisions in High-Risk Patients
por: Hobohm, Lukas, et al.
Publicado: (2022)

Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism
por: Schmitt, Volker H, et al.
Publicado: (2021)

Contemporary optimized practice in the management of pulmonary sarcoidosis
por: Aryal, Shambhu, et al.
Publicado: (2019)

High-sensitivity troponin I for risk stratification in normotensive pulmonary embolism
por: Ebner, Matthias, et al.
Publicado: (2020)

Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy
por: Packard, Elizabeth, et al.
Publicado: (2022)

The 2019 European guidelines on pulmonary embolism illustrated with the aid of an exemplary case report
por: Gallo, Andrea, et al.
Publicado: (2021)

Chrysin: Perspectives on Contemporary Status and Future Possibilities as Pro-Health Agent
por: Stompor-Gorący, Monika, et al.
Publicado: (2021)

A simple score for rapid risk assessment of non-high-risk pulmonary embolism
por: Lankeit, Mareike, et al.
Publicado: (2012)

Revised Paradigm for Acute Pulmonary Embolism Prognostication and Treatment
por: Jiménez, David, et al.
Publicado: (2023)

Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial
por: Sanchez, Olivier, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2oc81kfdl3j83gf7q81dilm314